The American College of Medical Genetics and Genomics (ACMG) is a professional organization based in the United States, established in 1991. With a workforce of 51 to 200 employees, ACMG focuses on the advancement of medical genetics and genomics through education, research, and the development of clinical guidelines. The organization's recent publication, titled "The clinical application of polygenic risk scores: A points to consider statement," addresses the use of polygenic risk scores (PRS) in clinical settings. This document serves as an educational resource for medical geneticists and clinicians, outlining the limitations and challenges associated with PRS. It emphasizes the importance of professional judgment in determining the appropriateness of specific procedures and tests, while encouraging clinicians to document their rationale for using particular methodologies. ACMG's work is grounded in the goal of enhancing the quality of medical services provided to patients, reflecting its commitment to evidence-based practice in the field of genetics and genomics.